KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Debt Ratio (2018 - 2022)

TherapeuticsMD's Debt Ratio history spans 8 years, with the latest figure at 0.01 for Q3 2022.

  • For Q3 2022, Debt Ratio fell 98.53% year-over-year to 0.01; the TTM value through Sep 2022 reached 0.01, down 98.53%, while the annual FY2021 figure was 1.11, 15.12% down from the prior year.
  • Debt Ratio reached 0.01 in Q3 2022 per TXMD's latest filing, down from 0.62 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.52 in Q1 2022 to a low of 0.01 in Q3 2022.
  • Average Debt Ratio over 5 years is 0.8, with a median of 0.78 recorded in 2019.
  • Peak YoY movement for Debt Ratio: skyrocketed 151.28% in 2019, then crashed 98.53% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.35 in 2018, then skyrocketed by 111.39% to 0.73 in 2019, then surged by 78.86% to 1.31 in 2020, then fell by 15.12% to 1.11 in 2021, then tumbled by 98.82% to 0.01 in 2022.
  • Per Business Quant, the three most recent readings for TXMD's Debt Ratio are 0.01 (Q3 2022), 0.62 (Q2 2022), and 1.52 (Q1 2022).